Trade Mark Journal No.2026/005 30 January 2026
WO0000001896690 (5,42)
Office of origin: United States of America
Date of International Registration:5 December 2025
Date of designation in the UK:
5 December 2025

International priority date claimed: 16 July 2025
(United States of America)
(99287857)
- Class 5
- Pharmaceutical preparations for the treatment and prevention of cancer and autoimmune disorders and diseases; therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and diseases; anti-cancer preparations; immunosuppressive pharmaceutical preparations.
- Class 42
- Pharmaceutical research and development; scientific research and development; research and development in the field of medical preparations, drug discovery, oncology, autoimmunity, and immunology.
Cullinan Therapeutics, Inc.
Representative: Malaika D. Tyson Lathrop GPM LLP, 155 N. Wacker Drive, Suite 3800, Chicago IL 60606, UNITED STATES OF AMERICA